HEARTBEAM INC (BEAT) Stock Price & Overview
NASDAQ:BEAT • US42238H1086
The current stock price of BEAT is 1.4 USD. Today BEAT is down by 0%. In the past month the price increased by 8.53%. In the past year, price decreased by -36.07%.
BEAT Key Statistics
- Market Cap
- 48.216M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.66
- Dividend Yield
- N/A
BEAT Stock Performance
BEAT Stock Chart
BEAT Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BEAT. When comparing the yearly performance of all stocks, BEAT is one of the better performing stocks in the market, outperforming 86.4% of all stocks.
BEAT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to BEAT. BEAT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
BEAT Earnings
BEAT Forecast & Estimates
10 analysts have analysed BEAT and the average price target is 5.48 USD. This implies a price increase of 291.61% is expected in the next year compared to the current price of 1.4.
BEAT Groups
Sector & Classification
BEAT Financial Highlights
Over the last trailing twelve months BEAT reported a non-GAAP Earnings per Share(EPS) of -0.66. The EPS increased by 5.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -716.97% | ||
| ROE | -5078.82% | ||
| Debt/Equity | 0 |
BEAT Ownership
BEAT Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.08 | 193.084B | ||
| ISRG | INTUITIVE SURGICAL INC | 47.96 | 176.393B | ||
| SYK | STRYKER CORP | 24.11 | 141.687B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20.37 | 108.246B | ||
| IDXX | IDEXX LABORATORIES INC | 41.06 | 49.421B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.46 | 48.681B | ||
| BDX | BECTON DICKINSON AND CO | 10.61 | 48.418B | ||
| RMD | RESMED INC | 20.59 | 37.195B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.79 | 35.143B | ||
| DXCM | DEXCOM INC | 26.97 | 27.57B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.99 | 18.52B | ||
| PODD | INSULET CORP | 37.39 | 16.95B | ||
| HOLX | HOLOGIC INC | 15.05 | 16.91B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About BEAT
Company Profile
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Company Info
HEARTBEAM INC
2118 Walsh Ave., Suite 210
Santa Clara CALIFORNIA 19355 US
CEO: Joseph H. Capper
Employees: 16
Phone: 14088994443
HEARTBEAM INC / BEAT FAQ
What does BEAT do?
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. The company is headquartered in Santa Clara, California and currently employs 16 full-time employees. The company went IPO on 2021-10-14. The firm focuses on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The company is engaged in the development of higher resolution ECG solutions is achieved through the development of the Company’s proprietary and patented electrocardiography technology platform. The company is developing three-dimensional (3D) representations of cardiac electrical activity by displaying the spatial locations of ECG waveforms. The company is developing its own product, the HeartBeam System. The HeartBeam System comprises a credit card sized 12-lead output electrocardiogram device, a patient application, a physician portal, and powerful cloud-based algorithms. The core technology consists of a series of patented inventions that allow it to capture the heart’s electrical activity from three distinct directions.
Can you provide the latest stock price for HEARTBEAM INC?
The current stock price of BEAT is 1.4 USD.
Does HEARTBEAM INC pay dividends?
BEAT does not pay a dividend.
How is the ChartMill rating for HEARTBEAM INC?
BEAT has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
How is the valuation of HEARTBEAM INC (BEAT) based on its PE ratio?
HEARTBEAM INC (BEAT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.66).
Can you provide the short interest for BEAT stock?
The outstanding short interest for HEARTBEAM INC (BEAT) is 7.32% of its float.